Literature DB >> 23197024

Trial watch: Phase III success for first-in-class pulmonary hypertension drug.

Man Tsuey Tse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23197024     DOI： 10.1038/nrd3906

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  3 in total

Review 1.  Pulmonary arterial hypertension: the clinical syndrome.

Authors:  Yen-Chun Lai; Karin C Potoka; Hunter C Champion; Ana L Mora; Mark T Gladwin
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 2.  New insights into the role of soluble guanylate cyclase in blood pressure regulation.

Authors:  Emmanuel Buys; Patrick Sips
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-03       Impact factor: 2.894

3.  Riociguat reduces infarct size and post-infarct heart failure in mouse hearts: insights from MRI/PET imaging.

Authors:  Carmen Methner; Guido Buonincontri; Chou-Hui Hu; Ana Vujic; Axel Kretschmer; Stephen Sawiak; Adrian Carpenter; Johannes-Peter Stasch; Thomas Krieg
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.